Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.2K Buy
7,723
+4,390
+132% +$46.1K ﹤0.01% 5595
2026
Q1
$30.2K Sell
3,333
-4,501
-57% -$54.4K ﹤0.01% 5627
2025
Q4
$96.8K Buy
7,834
+2,989
+62% +$39.8K ﹤0.01% 5405
2025
Q3
$64.9K Buy
+4,845
New +$66.2K ﹤0.01% 5478

Other funds holding CARL

Wells Fargo's CARL Position: Q2 2026 in Review

Wells Fargo increased its Carlsmed (CARL) stake by 132% in Q2 2026, buying an estimated $46.1K and bringing the position to 7,723 shares worth $80.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5595.

Wells Fargo first reported a position in CARL in Q3 2025 and has held it in 4 quarters since. The position peaked at $96.8K in Q4 2025. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Wells Fargo held 7,723 shares of Carlsmed worth $80.2K as of Q2 2026.
  • Wells Fargo bought 4,390 Carlsmed shares in Q2 2026, an estimated $46.1K.
  • Carlsmed made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5595 holding.
  • Wells Fargo first reported a position in Carlsmed in Q3 2025 and has held it in 4 quarters since.
  • Wells Fargo's Carlsmed position peaked at $96.8K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.